#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

byKathleen Lau

September 16, 2021

in StudyGraphics

Detection of pathogenic genetic variants in early-onset atrial fibrillation

RelatedReports

Pediatrics Classics

Parental input in oncology-related palliation and pain relief for children [Classics Series]

September 20, 2022

Screening insufficient for newborns exposed to hepatitis C virus

Chronic Disease

Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance

September 19, 2022

Oncology

Adjuvant pembrolizumab increased disease-free survival in completely resected, PD-L1 unselected non-small-cell lung cancer patients

September 19, 2022

Vitamin and supplement data remains limited, may provide no benefit

Cardiology

Rivaroxaban does not prevent cardiovascular events in rheumatic heart disease patients with atrial fibrillation

September 15, 2022

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Mental health in young adults may be linked to sleep chronotype

#Visual Abstract Watchful waiting may be an appropriate strategy for some patients with basal cell carcinomas

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

Parental input in oncology-related palliation and pain relief for children [Classics Series]

Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance

Adjuvant pembrolizumab increased disease-free survival in completely resected, PD-L1 unselected non-small-cell lung cancer patients

Detection of pathogenic genetic variants in early-onset atrial fibrillation

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

RelatedReports

Parental input in oncology-related palliation and pain relief for children [Classics Series]

Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance

Adjuvant pembrolizumab increased disease-free survival in completely resected, PD-L1 unselected non-small-cell lung cancer patients

Rivaroxaban does not prevent cardiovascular events in rheumatic heart disease patients with atrial fibrillation

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

Mental health in young adults may be linked to sleep chronotype

#Visual Abstract Watchful waiting may be an appropriate strategy for some patients with basal cell carcinomas

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

RELATED REPORTS

Detection of pathogenic genetic variants in early-onset atrial fibrillation

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports